Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
Authors:
- J.P DelamereJDJ.P Delamere
- S JobsonSJS Jobson
- L.P MackintoshLML.P Mackintosh
- L WellsLWL Wells
- K.W WaltonKWK.W Walton
Open Access
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 42 (5) , 500-504
Abstract
The clinical features and genetic background of 18 patients with rheumatoid arthritis were investigated following the development of penicillamine-induced myasthenia (PIM). The initial myasthenia symptoms in all patients consisted of variable diplopia and/or ptosis with progression to a more generalized involvement in 7 of them. No clinical, humoral, or genetic factor was determined which would allow identification of individuals developing generalized as opposed to ocular myasthenia. Withdrawal of penicillamine was associated over 4-60 weeks with a slow resolution of symptoms, facilitated in 12 patients by the use of anticholinesterase agents. In 2 patients a persistent partial unilateral ptosis remains after 15 and 25 months, while in a further patient diplopia is present 42 months after resolution of the other myasthenic symptoms. The patients with PIM when compared with a healthy 'control' population had a significant increase in HLA Dr1 (p corr less than 0.005) and an absence of HLA Dr 3. A genetic susceptibility to the development of PIM, distinct from that observed in myasthenia gravis of spontaneous onset, is suggested by this abnormal distribution of HLA Dr antigens.Keywords
This publication has 23 references indexed in Scilit:
- A Prospective Trial of D-Penicillamine in Primary Biliary CirrhosisNew England Journal of Medicine, 1982
- DR antigens and rheumatoid arthritis: a study of two populations.BMJ, 1981
- HLA-DR Antigens and Toxic Reaction to Sodium Aurothiomalate and D-Penicillamine in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 1980
- HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITYThe Lancet, 1980
- HLA-DRw4 AND RHEUMATOID ARTHRITISThe Lancet, 1979
- Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.BMJ, 1978
- Very close linkage between HLA-B and Bf inferred from allelic associationNature, 1977
- Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bw15European Journal of Immunology, 1976
- IMMUNE RESPONSE GENES IN MYASTHENIA GRAVISThe Lancet, 1973
- GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEINJournal of Experimental Medicine, 1972